Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · January 01, 2024

Circulating Tumor Cell Prediction in Patients With HR+/HER2− Advanced Breast Cancer

The Oncologist


Additional Info

The Oncologist
Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 Trial
Oncologist 2023 Nov 03;[EPub Ahead of Print], L Gerratana, M Kocherginsky, AA Davis, P D'Amico, C Reduzzi, F Puglisi, M Cristofanilli

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading